Palisade Bio Inc (PALI)
6.46
+0.08
(+1.25%)
USD |
NASDAQ |
May 16, 16:00
6.67
+0.21
(+3.25%)
After-Hours: 20:00
Palisade Bio Total Return Price: 6.46 for May 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 16, 2024 | 6.46 |
| May 15, 2024 | 6.38 |
| May 14, 2024 | 6.24 |
| May 13, 2024 | 6.22 |
| May 10, 2024 | 6.71 |
| May 09, 2024 | 6.94 |
| May 08, 2024 | 7.06 |
| May 07, 2024 | 7.90 |
| May 06, 2024 | 8.46 |
| May 03, 2024 | 7.74 |
| May 02, 2024 | 7.29 |
| May 01, 2024 | 7.08 |
| April 30, 2024 | 6.03 |
| April 29, 2024 | 6.18 |
| April 26, 2024 | 6.05 |
| April 25, 2024 | 6.23 |
| April 24, 2024 | 6.35 |
| April 23, 2024 | 5.92 |
| April 22, 2024 | 4.93 |
| April 19, 2024 | 4.71 |
| April 18, 2024 | 5.07 |
| April 17, 2024 | 6.60 |
| April 16, 2024 | 5.93 |
| April 15, 2024 | 4.16 |
| April 12, 2024 | 4.12 |
| Date | Value |
|---|---|
| April 11, 2024 | 4.38 |
| April 10, 2024 | 4.07 |
| April 09, 2024 | 5.42 |
| April 08, 2024 | 6.03 |
| April 05, 2024 | 5.542 |
| April 04, 2024 | 5.752 |
| April 03, 2024 | 5.835 |
| April 02, 2024 | 5.736 |
| April 01, 2024 | 5.853 |
| March 28, 2024 | 5.986 |
| March 27, 2024 | 5.930 |
| March 26, 2024 | 5.592 |
| March 25, 2024 | 5.442 |
| March 22, 2024 | 5.612 |
| March 21, 2024 | 5.847 |
| March 20, 2024 | 5.674 |
| March 19, 2024 | 5.55 |
| March 18, 2024 | 5.440 |
| March 15, 2024 | 5.408 |
| March 14, 2024 | 5.512 |
| March 13, 2024 | 5.672 |
| March 12, 2024 | 5.61 |
| March 11, 2024 | 5.892 |
| March 08, 2024 | 5.79 |
| March 07, 2024 | 5.871 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
4.07
Minimum
Apr 10 2024
42300.00
Maximum
May 29 2019
3354.98
Average
1822.50
Median
Oct 04 2021
Total Return Price Benchmarks
| TG Therapeutics Inc | 17.42 |
| Protagenic Therapeutics Inc | 1.49 |
| Bio-Path Holdings Inc | 2.34 |
| Jaguar Health Inc | 0.2867 |
| Finch Therapeutics Group Inc | 1.92 |